Quarterly report pursuant to Section 13 or 15(d)

Equity (Details)

v3.5.0.2
Equity (Details)
9 Months Ended
Sep. 30, 2016
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of Shares, Outstanding Balance | shares 200,000
Number of Shares, Granted | shares 460,000
Number of Shares, Cancelled | shares (150,000)
Number of Shares, Outstanding Balance | shares 510,000
Number of Shares, Exercisable | shares 50,000
Weighted Average Exercise Price, Outstanding Balance | $ / shares $ 0.20
Weighted Average Exercise Price, Granted | $ / shares 5.83
Weighted Average Exercise Price, Cancelled | $ / shares 0.20
Weighted Average Exercise Price, Outstanding Balance | $ / shares 5.28
Weighted Average Exercise Price, Exercisable | $ / shares $ 0.20
Weighted Average Remaining Contractual Term (in years), Outstanding 9 years 3 months 14 days
Weighted Average Remaining Contractual Term (in years), Exercisable 3 years 8 months 1 day
Aggregate Intrinsic Value, Outstanding Balance | $ $ 275,500
Aggregate Intrinsic Value, Exercisable | $ $ 275,500